Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
J&J's Still Mulling acquisitions Amid $10 Billion Share Buyback
Wednesday, October 14, 2015Johnson Johnson executives embarking on a billion share buyback program emphasized Tuesday they still have the cash and the appetite for deals I wouldnt interpret the billion share buyback as impacting our appetite for scale of any size in MA at...
Pharm-Olam International expands to larger facility in Poland
Wednesday, October 14, 2015PharmOlam International Ltd a multinational fullservice Clinical Research Solutions Organization CRO to biopharmaceutical and device industries is proud to announce the relocation of its Polish location to a larger office to accommodate for its growi...
Futura licenses erectile dysfunction drug to Quantum Pharma
Wednesday, October 14, 2015Futura Medical Plc has outlicensed exclusive rights to Quantum Pharma for manufacture and supply of med as an unlicensed medicine special in UK Signed an agreement under which med Futuras novel treatment for erectile dysfunction will soon be availab...
Merck KGaA bets on cancer drugs to revitalise German firm
Tuesday, October 13, 2015Merck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its bestselling medicine multiple sclerosis treatment Rebif Luciano Rossetti head of global research and development at Mercks biopharma...
Progenics Pharmaceuticals makes tender offer for in Exini Diagnostics
Tuesday, October 13, 2015Progenics Pharmaceuticals Inc has on Oct announced offer to tender all of shares in Exini for a consideration of Swedish crowns per share Says total value based on issued shares in Exini amounts to about million Swedish crowns million Offer pr...
Eli Lilly halts study of heart drug, stock tumbles
Tuesday, October 13, 2015Eli Lilly and Co has stopped a latestage trial of its closely watched cholesterol treatment after it proved ineffective sending its stock down more than percent and casting greater skepticism over the potentially lucrative class of medicines The se...
Hepalink Pharma's US unit plans to invest in Quest PharmaTech, OncoQuest
Monday, October 12, 2015Shenzhen Hepalink Pharmaceutical Co Ltd Says its US unit Hepalink USA Inc plans to invest C million in Quest PharmaTech Inc by subscribing million new shares Says its US unit Hepalink USA Inc plans to invest million in OncoQuest Inc by subscribing...
Novartis buys another 2.5 percent stake in Israel's Gamida Cell
Monday, October 12, 2015Swiss drugmaker Novartis will invest up to an extra million in Gamida Cell an Israeli developer of stem cell therapies Gamida said on Sunday Novartis last year invested million in the company for a percent stake in a deal that could reach millio...
FDA expands lung cancer approval for Bristol-Myers' drug
Saturday, October 10, 2015The US Food and Drug Administration on Friday expanded its approval of BristolMyers Squibb Cos immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer The agency said Opdivo may now be used in patients with nonsquamous...
India's Cipla ties up with Serum Institute to sell vaccines in South Africa
Friday, October 09, 2015Cipla Ltd Indias fourthlargest drugmaker by sales said on Thursday it had agreed to an exclusive deal with Serum Institute of India to supply vaccines to South Africa adding a new market to their partnership in India and Europe Ciplas unit Cipla Med...
